DrugPatentWatch Database Preview
Patent: 10,105,415
Try a free trial
See Plans and Pricing
Summary for Patent: 10,105,415
| Title: | Compositions comprising granulocyte-macrophage colony-stimulating factor for the treatment of inflammatory bowel disease |
| Abstract: | The present invention provides compositions comprising granulocyte-macrophage colony-stimulating factor and fosfomycin for the treatment, prevention or alleviation of an inflammatory bowel disease such as Crohn\'s disease, ulcerative colitis or necrotizing enterocolitis of newborn and premature infants by administration of the compositions into the intestinal lumen. |
| Inventor(s): | Heslet; Lars (Gentofte, DK), Uttenthal; Lars Otto (Salamanca, ES) |
| Assignee: | Reponex Pharmaceuticals A/S (Horsholm, DK) |
| Application Number: | 15/328,426 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,105,415
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Berlex Labs | LEUKINE | sargramostim | VIAL | 103362 | 001 | 1991-03-05 | ➤ Sign Up | Reponex Pharmaceuticals A/S (Horsholm, DK) | 2034-07-24 | RX | search | |
| Berlex Labs | LEUKINE | sargramostim | VIAL | 103362 | 002 | 1991-03-05 | ➤ Sign Up | Reponex Pharmaceuticals A/S (Horsholm, DK) | 2034-07-24 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 10,105,415
| Country | Patent Number | Publication Date |
|---|---|---|
| European Patent Office | 3171887 | May 31, 2017 |
| United States of America | 2017196937 | Jul 13, 2017 |
| World Intellectual Property Organization (WIPO) | 2016012608 | Jan 28, 2016 |
| >Country | >Patent Number | >Publication Date |
